American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals

Mechanick, Jeffrey I.; Brett, Elise M.; Chausmer, Arthur B.; Dickey, Richard A.; Wallach, Stanley; Bergman, Donald A.; Garber, Jeffrey R.; Hamilton, Carlos R.; Handelsman, Yehuda; Holdy, Kalman E.; Kukora, John S.; Levy, Philip; Palumbo, Pasquale; Petak, Steven M.; Poretsky, Leonid; Rabito, Philip; Rettinger, Herbert I.; Rodbard, Helena W.; Shankar, Talla P.; Hensrud, Donald D.

doi:10.4158/ep.9.5.417

Cited by 63 publications

(23 citation statements)

References 499 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Eligible guidelines were published in 2003 or later in Canada, the United States, United Kingdom, China, and Australia [40–56]. The guidelines were funded and/or developed by professional associations or societies (13), academic (3), and an international agency (1).…”

Section: Resultsmentioning

confidence: 99%

“…Appraisers agreed in their overall recommendation for 13 of 17 guidelines including 2 No [52, 55], and 11 Yes with modifications [40–43, 47–49, 51, 53, 54, 56]. Of the remaining four guidelines, three were rated by the two appraisers as No and Yes with modifications [44, 45, 50], while 1 guideline was rated at Yes and Yes with modifications [46].…”

Section: Resultsmentioning

confidence: 99%

“…Most guidelines thoroughly in detailed the characteristics of the members of the guideline development group, typically including degrees held by, and institutional affiliation of each member, in addition to some of the following: subject discipline, geographical location, and description of member’s role in the group [41–44, 46–49, 53–56]. Some guidelines detailed the views and preferences of the target population [44, 46, 53, 56] while most did not [40–43, 45, 47–52, 54, 55].…”

Section: Resultsmentioning

confidence: 99%

“…Some guidelines detailed the views and preferences of the target population [44, 46, 53, 56] while most did not [40–43, 45, 47–52, 54, 55]. Target users of the guideline were typically inconsistently defined.…”

Section: Resultsmentioning

confidence: 99%

“…Target users of the guideline were typically inconsistently defined. Some guidelines offered clear descriptions, for example, type of practitioner, specialty [40, 46, 49, 50, 52, 53, 56], while other guidelines offered few details about target users [43, 45, 47, 50, 54, 55]. …”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

The quantity and quality of complementary and alternative medicine clinical practice guidelines on herbal medicines, acupuncture and spinal manipulation: systematic review and assessment using AGREE II

Liang

Gagliardi

2016

BMC Complement Altern Med

View full text Add to dashboard Cite

BackgroundComplementary and alternative medicine (CAM) use is often not disclosed by patients, and can be unfamiliar to health care professionals. This may lead to underuse of beneficial CAM therapies, and overuse of other CAM therapies with little proven benefit or known contraindications. No prior research has thoroughly evaluated the credibility of knowledge-based resources. The purpose of this research was to assess the quantity and quality of CAM guidelines.MethodsA systematic review was conducted to identify CAM guidelines. MEDLINE, EMBASE and CINAHL were searched in January 2016 from 2003 to 2015. The National Guideline Clearinghouse, National Center for Complementary and Integrative Health web site, and two CAM journals were also searched. Eligible guidelines published in English language by non-profit agencies on herbal medicine, acupuncture, or spinal manipulation for adults with any condition were assessed with the Appraisal of Guidelines, Research and Evaluation II (AGREE II) instrument.ResultsFrom 3,126 unique search results, 17 guidelines (two herbal medicine, three acupuncture, four spinal manipulation, eight mixed CAM therapies) published in 2003 or later and relevant to several clinical conditions were eligible. Scaled domain percentages from highest to lowest were clarity of presentation (85.3 %), scope and purpose (83.3 %), rigour of development (61.2 %), editorial independence (60.1 %), stakeholder involvement (52.0 %) and applicability (20.7 %). Quality varied within and across guidelines. None of the 17 guidelines were recommended by both appraisers; 14 were recommended as Yes or Yes with modifications.ConclusionsGuidelines that scored well could be used by patients and health care professionals as the basis for discussion about the use of these CAM therapies. In future updates, guidelines that achieved variable or lower scores could be improved according to specifications in the AGREE II instrument, and with insight from a large number of resources that are available to support guideline development and implementation. Future research should identify CAM therapies other than those reviewed here for which guidelines are available. Research is also needed on the safety and effectiveness of CAM therapies.Electronic supplementary materialThe online version of this article (doi:10.1186/s12906-016-1410-8) contains supplementary material, which is available to authorized users.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

The quantity and quality of complementary and alternative medicine clinical practice guidelines on herbal medicines, acupuncture and spinal manipulation: systematic review and assessment using AGREE II

Liang

Gagliardi

2016

BMC Complement Altern Med

View full text Add to dashboard Cite

show abstract

Mining marine shellfish wastes for bioactive molecules: Chitin and chitosan – Part B: Applications

Hayes

Carney

Slater

et al. 2008

Biotechnology Journal

View full text Add to dashboard Cite

Due to their unique chemical characteristics (including biodegradability to non-toxic products, physiological inertness and hydrophilicity), chitin, chitosan and their derivatives may be expansively utilized in the biotechnological, agricultural, food protection and nutraceutical, medicinal and pharmacological fields and in the areas of bioremediation and gene therapy. Biological actions associated with chitin and shell waste by-products include among others antibacterial, angiotensin-1-converting enzyme-inhibitory and immunomodulatory activities, while the chitinolytic microbes and enzymes associated with chitinolysis also play a role in the de novo generation of further bioactivites. In Part B of this review we relate in more detail some of the bioactivities and applications of chitin and shell waste by-products.

show abstract

Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists

Mechanick

Apovian

Brethauer

et al. 2020

Obesity

Self Cite

323

464

View full text Add to dashboard Cite

Objective The development of these updated clinical practice guidelines (CPGs) was commissioned by the American Association of Clinical Endocrinologists (AACE), The Obesity Society (TOS), American Society for Metabolic and Bariatric Surgery (ASMBS), Obesity Medicine Association (OMA), and American Society of Anesthesiologists (ASA) Boards of Directors in adherence with the AACE 2017 protocol for standardized production of CPGs, algorithms, and checklists. Methods Each recommendation was evaluated and updated based on new evidence from 2013 to the present and subjective factors provided by experts. Results New or updated topics in this CPG include: contextualization in an adiposity‐based chronic disease complications‐centric model, nuance‐based and algorithm/checklist‐assisted clinical decision‐making about procedure selection, novel bariatric procedures, enhanced recovery after bariatric surgery protocols, and logistical concerns (including cost factors) in the current health care arena. There are 85 numbered recommendations that have updated supporting evidence, of which 61 are revised and 12 are new. Noting that there can be multiple recommendation statements within a single numbered recommendation, there are 31 (13%) Grade A, 42 (17%) Grade B, 72 (29%) Grade C, and 101 (41%) Grade D recommendations. There are 858 citations, of which 81 (9.4%) are evidence level (EL) 1 (highest), 562 (65.5%) are EL 2, 72 (8.4%) are EL 3, and 143 (16.7%) are EL 4 (lowest). Conclusions Bariatric procedures remain a safe and effective intervention for higher‐risk patients with obesity. Clinical decision‐making should be evidence based within the context of a chronic disease. A team approach to perioperative care is mandatory, with special attention to nutritional and metabolic issues.

show abstract

American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals

Cited by 63 publications

References 499 publications

The quantity and quality of complementary and alternative medicine clinical practice guidelines on herbal medicines, acupuncture and spinal manipulation: systematic review and assessment using AGREE II

The quantity and quality of complementary and alternative medicine clinical practice guidelines on herbal medicines, acupuncture and spinal manipulation: systematic review and assessment using AGREE II

Mining marine shellfish wastes for bioactive molecules: Chitin and chitosan – Part B: Applications

Contact Info

Product

Resources

About